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SUMMARY
A longitudinal study was conducted in a low endemic area in northern Tanzania to examine the in-
ﬂuence of the a-thalassaemia trait on malaria incidence and antibody responses to malaria apical
membrane antigen-1 (AMA-1) and merozoite surface protein1-19 (MSP-119). Out of 394 children
genotyped for a-thalassaemia trait, 4.1% (16 of 394) and 30.7% (121 of 394) were homozygous and
heterozygous, respectively. During the 1 year follow-up, four incidents of malaria cases were de-
tected without an evident association with a-thalassaemia. Being heterozygous or homozygous for
a-thalassaemia was associated with an increased prevalence of antibodies to AMA-1 [odds ratio
(OR): 1.83, 95% conﬁdence interval (CI): 1.07–3.12, p¼ 0.027] and MSP-1 (OR: 2.04, 95% CI:
1.16–3.60, p¼ 0.013) after adjustment for age and reported bednet use. The observed association
between a-thalassaemia and malaria antibody responses may reﬂect longer-term differences in anti-
gen exposure or differences in antibody acquisition upon exposure in this low endemic setting.
KEYWORDS : malaria, immunity, thalassaemia.
INTRODUCTION
Several human genetic traits have been associated
with protection against malaria or malaria mortality
[1–3]. a-Thalassaemia is associated with protection
against malaria-associated anaemia [4], severe mal-
aria but not against asymptomatic infection [5] and
probably not against uncomplicated disease [6].
The precise mechanisms by which a-thalassaemia
VC The Author [2015]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com
 139
Journal of Tropical Pediatrics, 2015, 61, 139–142
doi: 10.1093/tropej/fmu077
Advance Access Publication Date: 20 January 2015
Brief Report
Downloaded from https://academic.oup.com/tropej/article-abstract/61/2/139/1728368
by Radboud University user
on 13 December 2017
influences malaria risk is not well understood and
may involve impaired growth or an immunological
component [7]. It has been hypothesized that thalas-
saemic red blood cells have enhanced antibody bind-
ing and faster clearance of parasitized red blood cells
by the spleen [8, 9]. Improved antigen presentation
in the spleen may also result in a more efficient
acquisition of immune responses [8]. In this
study, we describe the associations between a-thalas-
saemia trait, protection against clinical malaria and
malaria-specific antibody responses in children living
in an area of low malaria endemicity in Tanzania.
MATERIALS AND METHODS
The study was conducted in Magugu in the Northern
Rift Valley in Tanzania in 2008–09. A total of 394
children aged 6 months–15 years were recruited and
followed for 12 months for malaria incidence. Passive
and active case detection was performed. Every 3
months, children were invited for cross-sectional sam-
pling during which a slide and rapid diagnostic test
(RDT) were taken. At enrolment, 2ml of blood was
collected by venipuncture from children for slide, and
filter paper blood spot. The prevalence of a-thalassae-
mia was determined by detection of the African a-glo-
bin deletion, a3.7, by polymerase chain reaction [10];
antibodies to apical membrane antigen-1 (AMA-1)
and merozoite surface protein-1 (MSP-119) were de-
tected by Enzyme Linked Immunosorbend Assay
[11]. Ethical clearance was given by the Kilimanjaro
Christians Medical Center Research Ethics
Committee and the Tanzanian National Institute for
Medical Research (NIMR/HQ/ R.8a / Vol.IX / 759).
Data were analysed using Statistical Package for Social
Sciences (SPSS) version 16.0 (SPSS Inc., Chicago, IL,
USA) and Stata version 12 (Statacorp, College
Station, TX, USA).
RESULTS AND DISCUSSION
After adjustment for age, mean haemoglobin con-
centrations were significantly lower in individuals
who were heterozygous [b¼0.43, SE (b)¼ 0.14,
p¼ 0.002] and homozygous for a-thalassaemia
[b¼1.04, SE (b)¼ 0.32, p¼ 0.001] compared
with wildtype individuals. Mild anaemia
(Hb< 11 g/dL) was diagnosed in 9.0% (23 of 257)
of the wildtype, 14.1% (17 of 121) of the heterozy-
gous and 25.0% (4 of 16) of the homozygous indi-
viduals for a-thalassaemia (p¼ 0.025). Anaemia and
lower Hb values in malaria-free individuals have pre-
viously been associated with a-thalassaemia [4, 12].
During the 1 year of follow-up, four clinical malaria
episodes were recorded, defined as a positive
Lactate Deshydrogenase-based RDT in the presence
of fever. The incidence of clinical malaria (1%)
and asymptomatic parasite prevalence (<5%) were
not significantly different between groups
Fig. 1. Age- and a thalassemia dependent prevalence
of antibodies against AMA-1 and MSP-1. Heterozygous
and homozygous individuals for a-thalassaemia are
combined in the category a-thalassaemia. An asterisk
indicates statistical signiﬁcance between thalassaemic and
non-thalassaemic individuals of this age group (p< 0.05).
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(p 0.47), possibly because malaria burden was too
low to allow meaningful analysis. Being heterozy-
gous or homozygous for a-thalassaemia was associ-
ated with an increased prevalence of antibodies to
AMA-1 [odds ratio (OR): 1.83, 95% confidence
interval (CI): 1.07–3.12, p¼ 0.027] and MSP-1
(OR: 2.04, 95% CI: 1.16–3.60, p¼ 0.013) after ad-
justment for age and reported bednet use. When
antibody prevalence was compared between wild-
type individuals and hetero-/homozygous individ-
uals in different age groups, the elevated antibody
prevalence in hetero-/homozygous individuals was
most evident in older age groups (Fig. 1). The oc-
currence of clinical malaria episodes during follow-
up, plausibly reflecting previous malaria exposure,
did not confound these associations. For HbAS
(heamoglobin type AS) and HbAC (heamoglobin
type AC), several studies have reported higher anti-
body prevalences against Plasmodium falciparum
antigens [13–15] that suggest that differences in
antibody responses may play a role in the conferred
protection against malaria. For a-thalassaemia, the
same association has not been established [12]. In
our study, malaria infections were too uncommon
to allow the formation of meaningful cohorts with
differential exposure to malaria to study antibody ac-
quisition in relation to malaria exposure. We can
therefore only speculate on the reasons for the posi-
tive association between antibody responses and
a-thalassaemia trait, which may reflect a more effi-
cient acquisition of antibody responses upon malaria
infection or a higher exposure to malaria infection
in a-thalassaemic individuals. This would explain
our finding that the difference between thalassaemic
and wildtype individuals becomes larger with
increasing age [16, 17].
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Table 1. Associations between a-thalassaemia and haemoglobin concentration, antibody prevalence
and malaria incidence and prevalence
Variables a-Thalassaemia
Wildtype Heterozygous Homozygous p-value
Proportion of study population (n/N) 65.2 (257/394) 30.7 (121/394) 4.1 (16/394) -
Age, median (IQR) 4 (3–7) 4 (3–6) 4 (3–9) 0.66
Haemoglobin
concentrations, mean (SD)
12.5 (1.3) 12.1 (1.3) 11.6 (1.4) <0.001
Enrolment anaemia,
% Hb< 11 g/dL (n/N)
9.0 (23/257) 14.1 (17/121) 25.0 (4/16) 0.027
Enrolment AMA-1
antibody prevalence
27.7 (71/256) 34.7 (42/121) 43.8 (7/16) 0.073
Enrolment MSP-119
antibody prevalence
18.7 (48/256) 25.6 (31/121) 43.8 (7/16) 0.014
Malaria incidence, % of children with
clinical malaria episode (n/N)
0.8 (2/257) 1.6 (2/121) 0.0 (0/16) 0.47
Parasite prevalence in all
surveys combined, % (n/N)
4.7 (12/257) 5.0 (6/121) 0 (0/16) 0.66
IQR¼ interquartile range.
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